Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$XENE

Xenon Pharmaceuticals Inc

XNASHealth CarePharmaceutical Preparations

$64.60+0.47%+$0.3000Prev $64.30LIVE Full chart Live alerts
No recent price bars, the chart lights up when XENE starts printing.

Why is XENE up today? It is at $64.60 (+0.47%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment XENE spikes, and full due diligence on XENE — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $XENE alerts the moment volume spikes

Our scanner flagged $XENE 10 times in the last 30 days. Create a free account to track $XENE, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$64.60
Change today
+0.47%
Previous close
$64.30
52-week range
$32.78 – $72.66
Valuation & dividend
Market cap
$6.22B
Ownership & volume
Shares outstanding
96.7M
SEC · as of 2026-05-04 · 94d
Insider ownership
3.0%
DEF 14A · 2026-04-22
Institutional own.
99.9%
Total held
100.0%
Avg daily volume
1.1M
Classification
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
XNAS
Relative volumevs this time of day
5m
0.4x
15m
0.3x
1h
0.5x
1D
0.0x

Get free XENE + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $XENE moving today?

Here is the latest on XENE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for XENE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Likely catalystExecutive / Board Change · Shareholder Vote, from the latest SEC filing. Read it →
Why is $XENE moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile⚡ Ultra-low floatShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy11 analysts
Avg target $75.88(+17% upside)
Range $63 – $86
11 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders selling0 buys, 4 sells last 3 months (0/16 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Cannon Gillian
Director
Sold (automatic/other)-1Ksold 45%1K$63K
at $53.14
Jun 5, 26
Patou Gary
Director
Sold (automatic/other)-1Ksold 5.0%25K$70K
at $53.14
Jun 5, 26
Svoronos Dawn
Director
Sold (automatic/other)-1Ksold 5.1%26K$76K
at $53.41
Jun 1, 26
Svoronos Dawn
Director
Other3Kadded 11%28Kn/aJun 1, 26
Cannon Gillian
Director
Other3Kn/a3Kn/aJun 1, 26
Gannon Steven
Director
Sold (automatic/other)-1Ksold 11%12K$76K
at $53.41
Jun 1, 26
Gannon Steven
Director
Other3Kadded 25%13Kn/aJun 1, 26
Garofalo Elizabeth A.
Director
Other3Kn/a3Kn/aJun 1, 26
Gover Justin D.
Director
Other3Kn/a3Kn/aJun 1, 26
Machado Patrick
Director
Other3Kn/a3Kn/aJun 1, 26
Patou Gary
Director
Other3Kadded 11%26Kn/aJun 1, 26
Gannon Steven
Director
Other4Kadded 49%11K$26K
at $7.38
May 12, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Recent offering

At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $XENE runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$XENE Sentiment

Bullish
Bearish79Bullish
📰 News: 4 bull · 0 bearToday: +0.5%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$XENE Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 19h ago +0.8% vs EMA
XENE 200EMA (5m) Trending · 74 bars · L3 · +0.77% above EMA · slope +0.13%
at $64.31
Alert· 1d ago 2.5× RVOL
XENE hit 2.459x RVOL at 10:48 AM ET
at $64.29
Alert· 3d ago -1.4% vs EMA
$XENE near 200 EMA: -1.39% from 200 EMA at 10:34 AM ET
at $61.92
Alert· 3d ago 9.0× RVOL
XENE hit 8.998x RVOL at 10:34 AM ET
at $61.92
Alert· 3d ago -1.91%
$XENE moved -1.91% in 1 min (Level 1) at 9:27 AM ET
at $62.80
Alert· 5d ago 5.0× RVOL
XENE hit 4.968x RVOL at 12:43 PM ET
at $62.84
Alert· 7d ago -1.04%
$XENE moved -1.04% in 1 min (Level 1) at 9:28 AM ET
at $63.30
Alert· 7d ago -1.61%
$XENE moved -1.61% in 1 min (Level 1) at 4:32 PM ET
at $61.00
Alert· 7d ago -1.0% vs EMA
$XENE near 200 EMA: -1.01% from 200 EMA at 1:20 PM ET
at $63.68
Alert· 7d ago 9.1× RVOL
XENE hit 9.137x RVOL at 1:20 PM ET
at $63.68
Alert· 9d ago 2.5× RVOL
XENE hit 2.503x RVOL at 10:24 AM ET
at $64.37
Alert· 15d ago -0.1% vs EMA
$XENE near 200 EMA: -0.11% from 200 EMA at 2:19 PM ET
at $66.23
Alert· 15d ago 7.4× RVOL
XENE hit 7.416x RVOL at 2:19 PM ET
at $66.23
Alert· 15d ago 5.4× RVOL
XENE hit 5.365x RVOL at 11:46 AM ET
at $66.07
News· GlobeNewswire Inc.· 56d ago Bullish
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
News· SEC EDGAR· 63d ago
Xenon Pharmaceuticals Inc. filed an 8-K: Executive / Board Change, Shareholder Vote
News· SEC EDGAR· 90d ago
Xenon Pharmaceuticals Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 90d ago
Xenon Pharmaceuticals Inc. filed an 8-K: Results of Operations, Regulation FD Disclosure
News· GlobeNewswire Inc.· 108d ago Bullish
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
News· SEC EDGAR· 114d ago
Xenon Pharmaceuticals Inc. filed an 8-K: Executive / Board Change
News· The Motley Fool· 131d ago Bullish
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know
News· GlobeNewswire Inc.· 148d ago Bullish
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering

Related PHARMACEUTICAL stocks

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

XENE stock FAQ

Why is $XENE moving today?

Here is the latest on XENE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for XENE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the XENE stock price today?

XENE last traded at $64.60, up 0.47% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live XENE alerts?

The XENE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged XENE 10 times in the last 30 days.

What exchange is XENE on?

XENE (Xenon Pharmaceuticals Inc) trades on XNAS, with a market cap of about $6.22B in the PHARMACEUTICAL PREPARATIONS sector.

Is XENE good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge XENE for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.